| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 3,221 | 2,621 | 5,277 | 4,054 | | Cost of Revenue | 4,477 | 2,703 | 12,122 | 5,629 | | | Gross Profit | (1,255) | (81) | (6,845) | (1,575) | | | Operating Expenses | | Research Development | 3,958 | 4,465 | 8,390 | 7,703 | | Selling General and Administrative | 4,454 | 3,239 | 8,696 | 4,755 | | Non Recurring |
-
|
-
| 45,843 |
-
| | Others | 525 | 506 | 514 | 563 | | | | Total Operating Expenses |
-
|
-
| 63,443 |
-
| | | | Operating Income or Loss | (10,192) | (8,291) | (70,287) | (14,595) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 260 | 430 | 5,779 | 1,071 | | Earnings Before Interest And Taxes | (9,932) | (7,861) | (64,509) | (13,524) | | Interest Expense | 318 | 296 | (213) | 286 | | Income Before Tax | (10,250) | (8,157) | (64,295) | (13,810) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,250) | (8,157) | (64,295) | (13,810) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,250) | (8,157) | (64,295) | (13,810) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,250) | ($8,157) | ($64,295) | ($13,810) |
|
2.03% Nasdaq 0.00%
Income Statement
